Clinical Trial Update: Safety and Efficacy Study of CBT-004 in Patients With Vascularized Pinguecula [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of CBT-004 for vascularized pinguecula has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pinguecula

Drugs mentioned

• CBT-004

Snippet

Sponsor: Cloudbreak Therapeutics, LLC | Conditions: Pinguecula | Phase 2 | Status: COMPLETED